12 November 2014

US Regulatory Burden, Innovation Breakdown by Joseph Gulfo

Book Review: 'Innovation Breakdown' by Joseph V. Gulfo - WSJ: ".... Compare MelaFind's experience in the U.S. with its reception in Europe: MelaFind was submitted for marketing approval in Europe in May 2011. It was approved just five months later. One key reason for Europe's efficient approval process is that European governments don't review medical devices directly. Instead they certify independent "notified bodies" that specialize and compete to review new products. The European system works more quickly than the U.S. system, and there is no evidence that it results in reduced patient safety. Rather than tweak the current system, why doesn't the U.S. just adopt the European model and call it a day? Our health and our economy would be better off for it. Google's Sergey Brin recently said that he didn't want to be a health entrepreneur because "It's just a painful business to be in . . . the regulatory burden in the U.S. is so high that I think it would dissuade a lot of entrepreneurs." Mr. Brin won't find anything in Dr. Gulfo's book to persuade him otherwise. Until we get our regulatory system in order, expect a lot more Yo's and not enough life-saving innovations."


more news below



No comments:

The 7 Habits of Highly Effective Mediocre Entrepreneurs | TechCrunch: " . . . . persistence is not the self-help cliche “Keep going until you hit the finish line!”. The key slogan is, “Keep failing until you accidentally no longer fail.” That’s persistence." - James Altucher

Both Sides of the Table

Venture Capital Dispatch

Startup News

Entrepreneur News

Angel Investor News

Venture Capital News

Venture Capital Survey

Business - SiliconValley.com

silicontap.com - Silicon Valley High Tech News

DealBook - NYTimes

You're the Boss - NYTimes

Bucks - NYTimes